KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Receivables - Other (2018 - 2025)

Historic Receivables - Other for Idexx Laboratories (IDXX) over the last 8 years, with Q3 2025 value amounting to $72.0 million.

  • Idexx Laboratories' Receivables - Other rose 1715.68% to $72.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.0 million, marking a year-over-year increase of 1715.68%. This contributed to the annual value of $60.8 million for FY2024, which is 1023.39% up from last year.
  • Per Idexx Laboratories' latest filing, its Receivables - Other stood at $72.0 million for Q3 2025, which was up 1715.68% from $67.9 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Receivables - Other high stood at $72.0 million for Q3 2025, and its period low was $26.6 million during Q1 2021.
  • Over the past 5 years, Idexx Laboratories' median Receivables - Other value was $50.1 million (recorded in 2023), while the average stood at $49.1 million.
  • As far as peak fluctuations go, Idexx Laboratories' Receivables - Other surged by 5845.95% in 2021, and later surged by 1023.39% in 2024.
  • Over the past 5 years, Idexx Laboratories' Receivables - Other (Quarter) stood at $37.8 million in 2021, then rose by 10.81% to $41.9 million in 2022, then soared by 31.67% to $55.1 million in 2023, then rose by 10.23% to $60.8 million in 2024, then increased by 18.44% to $72.0 million in 2025.
  • Its Receivables - Other stands at $72.0 million for Q3 2025, versus $67.9 million for Q2 2025 and $62.9 million for Q1 2025.